Cell and gene therapies promise life-changing treatments, but the pandemic has hit the sector hard. A survey reveals the extent of the disruption and suggests actions to help companies become more resilient
Cell and gene therapies promise life-changing treatments, but the pandemic has hit the sector hard. A survey reveals the extent of the disruption and suggests actions to help companies become more resilient
מלא פרטיך בטופס יצירת קשר ונציג מגדל שוקי הון יצור עמך קשר בהקדם!
